Benchmark Starts Exactech (EXAC) at Buy; Continued Strong Growth Makes For Attractive Takeover Candidate

May 18, 2012 8:17 AM EDT
Get Alerts EXAC Hot Sheet
Price: $26.60 --0%

Rating Summary:
    5 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 24 | New: 14
Trade EXAC Now!
Join SI Premium – FREE
Benchmark initiates coverage on Exactech Inc (NASDAQ: EXAC) with a Buy. PT $21.00.

Analyst, James Terwilliger, said, "We believe that the total worldwide market for orthopedic products is in excess of $30 billion...We believe that EXAC has a diversified product offering that includes knees, hips, extremities, spine and biologics. In terms of 2011 revenue, knee implants represented 39%, hip implants represented 16%, biologics and spine represented 12%, extremities represented 19% and Other products represented 13%. We believe that this diversified product mix makes EXAC an attractive acquisition candidate."

For an analyst ratings summary and ratings history on Exactech Inc click here. For more ratings news on Exactech Inc click here.

Shares of Exactech Inc closed at $16.50 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Add Your Comment